The paradox of NKp46+ natural killer cells: Drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment

Gut

Volumn 63, Issue 3, 2014, Pages 515-524

  Pembroke, Tom ^a   Christian, Adam ^b   Jones, Emma ^a   Hills, Robert K ^a   Wang, Eddie C Y ^a   Gallimore, Awen M ^a   Godkin, Andrew ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC VIRAL HEPATITIS; HEPATITIS C; IMMUNE-MEDIATED LIVER DAMAGE; IMMUNOLOGY IN HEPATOLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; HEPATIC INSUFFICIENCY; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LINEAR MODELS; LIVER; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RIBAVIRIN; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; VIRAL LOAD;

EID: 84893751509     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-304472     Document Type: Article

References (30)

1. Day C, Lauer G, Robbins G, et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 2002;76:12584-95. (Pubitemid 35386944)
2. Godkin A, Jeanguet N, Thursz M, et al. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol 2001;31:1438-46. (Pubitemid 32454691)
3. Golden-Mason L, Cox AL, Randall JA, et al. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro. Hepatology 2010;52:1581-9.
4. Knapp S, Warshow U, Ho KM, et al. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. Gastroenterology 2011;141:320-5.
5. Ahlenstiel G, Titerence RH, Koh C, et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa- dependent manner. Gastroenterology 2010;138:325-35.
6. Oliviero B, Varchetta S, Paudice E, et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009;137:1151-60.
7. Sene D, Levasseur F, Abel M, et al. Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog 2010;6:e1001184.
8. Nattermann J, Feldmann G, Ahlenstiel G, et al. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2006;55:869-77. (Pubitemid 43764560)
9. Bozzano F, Picciotto A, Costa P, et al. Activating NK cell receptor expression/ function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. Eur J Immunol 2011;41:2905-14.
10. Dessouki O, Kamiya Y, Nagahama H, et al. Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: reversion by anti-viral treatment. Biochem Biophys Res Commun 2010;393:331-7.
11. Bonorino P, Ramzan M, Camous X, et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 2009;51:458-67.
12. Edlich B, Ahlenstiel G, Azpiroz AZ, et al. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology 2012;55:39-48.
13. Kramer B, Korner C, Kebschull M, et al. Natural killer p46(High) expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Hepatology 2012;56:1201-13.
14. Varchetta S, Mele D, Mantovani S, et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 2012;56:841-9.
15. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
16. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004;294:15-22. (Pubitemid 39626587)
17. Pembroke T, Rees I, Gallagher K, et al. Rapid early innate control of hepatitis C virus during IFN-alpha treatment compromises adaptive CD4(+) T-cell immunity. Eur J Immunol 2012;42:2383-94.
18. Golden-Mason L, Stone AE, Bambha KM, et al. Race-and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis c virus immunity. Hepatology 2012;56:1214-22.
19. Davis GL, Wong JB, McHutchison JG, et al. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 2003;38:645-52. (Pubitemid 37052151)
20. Andrews DM, Estcourt MJ, Andoniou CE, et al. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J Exp Med 2010;207:1333-43.
21. Narni-Mancinelli E, Jaeger BN, Bernat C, et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 2012;335:344-8.
22. Norris S, Collins C, Doherty DG, et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998;28:84-90. (Pubitemid 28122504)
23. Kawarabayashi N, Seki S, Hatsuse K, et al. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000;32:962-9.
24. Yamagiwa S, Matsuda Y, Ichida T, et al. Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells. Hepatol Res 2008;38:664-72. (Pubitemid 351784979)
25. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001;409:1055-60. (Pubitemid 32204059)
26. Jarahian M, Fiedler M, Cohnen A, et al. Modulation of NKp30-and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog 2011;7:e1002195.
27. Brandt CS, Baratin M, Yi EC, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009;206:1495-503.
28. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 2008;105:7034-9. (Pubitemid 351754525)
29. Chen L, Borozan I, Feld J, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 2005;128:1437-44. (Pubitemid 40712193)
30. Su AI, Pezacki JP, Wodicka L, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 2002;99: 15669-74. (Pubitemid 35403989)